Added to YB: 2026-01-19
Pitch date: 2026-01-16
BSX [bullish]
Boston Scientific Corporation
-17.25%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$113.1B
Pitch Price
$88.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.61
P/E
39.29
EV/Sales
6.14
Sector
Health Care Equipment and Supplies
Category
special_situation
$BSX Puts Sold On This Acquisition Dip
BSX (options trade): Down 4% on $14.5B Penumbra acquisition, traders selling $80 puts (11.2% OTM) collecting $1.10 premium. High IV from deal + Feb 4 earnings creates opportunity. $80 strike near 52-week low $85.98, analysts maintain Buy ratings w/ $121-$127 targets. Risk: integration concerns.
Read full article (2 min)